海南医学
海南醫學
해남의학
HAINAN MEDICAL JOURNAL
2014年
15期
2297-2298,2299
,共3页
杨超%王威%杜静%周钧%彭彬%池繁武%温定国
楊超%王威%杜靜%週鈞%彭彬%池繁武%溫定國
양초%왕위%두정%주균%팽빈%지번무%온정국
肾下型腹主动脉瘤%腔内隔绝术%分支型支架
腎下型腹主動脈瘤%腔內隔絕術%分支型支架
신하형복주동맥류%강내격절술%분지형지가
Infrarenal Abdominal Aortic Aneurysm%Endovascular graft exclusion%Bifurcated endograft
目的:总结Ⅱb型肾下型腹主动脉瘤的腔内隔绝术治疗经验。方法2007年5月至2012年12月暨南大学第二临床医学院心血管外科应用分支型覆膜支架实施腔内隔绝术治疗20例Ⅱb型肾下型腹主动脉瘤患者。采用增强CT血管成像进行随访。结果8例患者成功植入Powerlink分支型支架8枚;12例患者成功植入Zenith分支型支架12枚,支架植入成功率为100%。随访10~65个月,所有支架形态正常,没有位移发生。术后1个月复查发现Ⅱ型内漏3例,6个月时复查内漏消失。术后无其他手术相关并发症发生。结论应用分支型支架腔内隔绝能安全有效地治疗Ⅱb型肾下型腹主动脉瘤。
目的:總結Ⅱb型腎下型腹主動脈瘤的腔內隔絕術治療經驗。方法2007年5月至2012年12月暨南大學第二臨床醫學院心血管外科應用分支型覆膜支架實施腔內隔絕術治療20例Ⅱb型腎下型腹主動脈瘤患者。採用增彊CT血管成像進行隨訪。結果8例患者成功植入Powerlink分支型支架8枚;12例患者成功植入Zenith分支型支架12枚,支架植入成功率為100%。隨訪10~65箇月,所有支架形態正常,沒有位移髮生。術後1箇月複查髮現Ⅱ型內漏3例,6箇月時複查內漏消失。術後無其他手術相關併髮癥髮生。結論應用分支型支架腔內隔絕能安全有效地治療Ⅱb型腎下型腹主動脈瘤。
목적:총결Ⅱb형신하형복주동맥류적강내격절술치료경험。방법2007년5월지2012년12월기남대학제이림상의학원심혈관외과응용분지형복막지가실시강내격절술치료20례Ⅱb형신하형복주동맥류환자。채용증강CT혈관성상진행수방。결과8례환자성공식입Powerlink분지형지가8매;12례환자성공식입Zenith분지형지가12매,지가식입성공솔위100%。수방10~65개월,소유지가형태정상,몰유위이발생。술후1개월복사발현Ⅱ형내루3례,6개월시복사내루소실。술후무기타수술상관병발증발생。결론응용분지형지가강내격절능안전유효지치료Ⅱb형신하형복주동맥류。
Objective To summarize the clinical experience of endovascular graft exclusion (EVGE) on treating type IIb infrarenal abdominal aortic aneurysms. Methods From May 2007 to December 2012, 20 patients with infrarenal abdominal aortic aneurysms (type IIb) were treated by endovascular graft exclusion in the department of cardiovascular surgery of second medical school of Jinan University. Contrast enhanced CT scans were done during the follow-up study. Results Eight powerlink stent grafts were implanted successfu1ly in 8 patients. 12 Zenith AAA Endovascular Grafts were implanted successfu1ly in 12 patients. During the 10~65 months follow-up period, the loca-tions and shapes of the stent-graft were stable in all patients. No displacement occured. TypeⅡendoleakage occurred in 3 cases, which automatically ceased 6 months after the procedure. No other complications occured. Conclusion Endo-vascular graft exclusion may be efficacious and safe in therapy of typeⅡb infrarenal abdominal aortic aneurysms.